[go: up one dir, main page]

JPS5770820A - Immunoregulating agent - Google Patents

Immunoregulating agent

Info

Publication number
JPS5770820A
JPS5770820A JP14571580A JP14571580A JPS5770820A JP S5770820 A JPS5770820 A JP S5770820A JP 14571580 A JP14571580 A JP 14571580A JP 14571580 A JP14571580 A JP 14571580A JP S5770820 A JPS5770820 A JP S5770820A
Authority
JP
Japan
Prior art keywords
formula
group
remedy
diseases
immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14571580A
Other languages
Japanese (ja)
Other versions
JPS6310924B2 (en
Inventor
Haruo Ogura
Hiroshi Takahashi
Toshiaki Osawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP14571580A priority Critical patent/JPS5770820A/en
Publication of JPS5770820A publication Critical patent/JPS5770820A/en
Publication of JPS6310924B2 publication Critical patent/JPS6310924B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To provide an immunoregulating agent containing a glucopyranosyl derivative.
CONSTITUTION: An immunoregulating agent containing the compound of formula I[R1 is H or -CH2OH; R2 is -NH-CS-NH-R3 (R3 is group of formula II, group of formula II, group of formula III, etc.), group of formula IV, etc.] e.g. N-(β-D-gluco- pyranosyl)-N'-(6-amino-1,3-dimethyl-2,4-dioxopyrimidin-5-yl) thioureide. The agent is useful for the remedy of diseases caused by the abnormality in immunity funtion or diseases accompanied by the abnormality of immunity function (e.g. remedy of cancer, prevention of metastatis of cancer, immunity suppression for transplantation of organs, remedy for collagen diseases and autoimmune diseases such as rheumatic arthritis, etc.).
COPYRIGHT: (C)1982,JPO&Japio
JP14571580A 1980-10-20 1980-10-20 Immunoregulating agent Granted JPS5770820A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14571580A JPS5770820A (en) 1980-10-20 1980-10-20 Immunoregulating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14571580A JPS5770820A (en) 1980-10-20 1980-10-20 Immunoregulating agent

Publications (2)

Publication Number Publication Date
JPS5770820A true JPS5770820A (en) 1982-05-01
JPS6310924B2 JPS6310924B2 (en) 1988-03-10

Family

ID=15391444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14571580A Granted JPS5770820A (en) 1980-10-20 1980-10-20 Immunoregulating agent

Country Status (1)

Country Link
JP (1) JPS5770820A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362055B2 (en) 2004-11-18 2013-01-29 Synta Pharmaceuticals, Inc. Triazole compounds that modulate HSP90 activity
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors
US9439899B2 (en) 2011-11-02 2016-09-13 Synta Pharmaceuticals Corp. Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors
US10500193B2 (en) 2011-11-02 2019-12-10 Synta Pharmaceuticals Corporation Combination therapy of HSP90 inhibitors with platinum-containing agents

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362055B2 (en) 2004-11-18 2013-01-29 Synta Pharmaceuticals, Inc. Triazole compounds that modulate HSP90 activity
US8901308B2 (en) 2004-11-18 2014-12-02 Synta Pharmaceuticals Corp. Triazole compounds that modulate Hsp90 activity
US9090569B2 (en) 2004-11-18 2015-07-28 Synta Pharmaceuticals Corp. Triazone compounds that modulate HSP90 activity
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
US9439899B2 (en) 2011-11-02 2016-09-13 Synta Pharmaceuticals Corp. Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors
US10500193B2 (en) 2011-11-02 2019-12-10 Synta Pharmaceuticals Corporation Combination therapy of HSP90 inhibitors with platinum-containing agents
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors

Also Published As

Publication number Publication date
JPS6310924B2 (en) 1988-03-10

Similar Documents

Publication Publication Date Title
TW271395B (en)
JPS5422371A (en) Trifluoromethylpyridoxyphenoxypropionic acid derivative and hericide containing the same
ES8801643A1 (en) Pharmaceutical compositions containing ascorbic acid derivatives.
ES2104090T3 (en) NEW 3 ', 5'-DI-T-BUTIL-4'-HIDROXI-FLAVONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
SE8801515D0 (en) PHARMACEUTICAL COMPOSITION
ATE60763T1 (en) PYRROLIDINYLAMIDE ESTER DERIVATIVES WITH ANTIPROLYLENE ENDOPEPTIDASE ACTIVITY, THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
JPS5791997A (en) 5'-o-acylnucleoside and its preparation
JPS5770820A (en) Immunoregulating agent
ES457784A1 (en) Basic substituted xanthine derivatives
JPS5799521A (en) Solid composition containing bisacodyl
AR007052A1 (en) A CARBOHYDRATE DERIVATIVE, ITS USE AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
MX9203585A (en) DERIVATIVES OF PHENOTIAZINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EP0790247A4 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
JPS5419969A (en) Proline derivative and its preparation
JPS56120700A (en) Cardiac stimmulant
JPS5371058A (en) Preparation of 1-substd.-3-substd. amino-4-substd.-thidazetidinone derivs.
JPS6434965A (en) Novel aconitine based compound and analgesic and antiphlogistic agent containing said compound as active ingredient
JPS5668611A (en) Novel antiallergic agent
NZ211846A (en) 2,3-diamino-2,3-didesoxyhexose derivatives and pharmaceutical compositions thereof
JPS56152476A (en) Novel minimycin derivative
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS54154714A (en) Nitrosourea derivative and its preparation
JPS53102985A (en) Cyclodextrin derivative and its produdtion
JPS5283451A (en) Preparation of 3-imino-substituted acylamino-2-azetidinone derivative
ES2089761T3 (en) NEW DERIVATIVES OF P- (DI- (2-CHLORINE-ETHL) -AMINO) -PHENYL-ALANINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.